Navigation Links
MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions

Two Contracts Awarded for Chemistry and Automation as well as Immunoassay

and Infectious Disease Solutions

TARRYTOWN, N.Y., Oct. 4 /PRNewswire/ -- Siemens Medical Solutions Diagnostics, (, announced today that it has been selected by MedAssets Supply Chain Systems, (, a Group Purchasing Organization (GPO) and supply chain management company, to provide Chemistry, Automation, and Immunoassay solutions for its facilities.

(Logo: )

"This award will provide an opportunity for Siemens to fulfill its goal of supporting both the customer and patient toward personalized patient care, through integrated chemistry, immunoassay and automation tools," said John Nosenzo, senior vice president and general manager, Americas Region, Siemens Medical Solutions Diagnostics.

Participating laboratories will be offered Siemens' full line of ADVIA(R) Chemistry Systems including the ADVIA 2400, 1800, and 1200 as well as immunochemistry systems such as the ADVIA Centaur(R) XP and CP. In addition, members will be offered automation solutions such as the ADVIA LabCell(R) and ADVIA WorkCell(R), which provide state-of-the-art platforms of automation, pre-analytical and post-analytical components that route samples for optimal efficiency. Plans to include the IMMULITE(R) family of immunoassay systems are underway to provide added value to the membership.

"MedAssets Supply Chain Systems has a great deal of experience providing cost-effective solutions that are critical to laboratory success," said Mary Ellen Kimmeth, vice president, Laboratory Division and Capital Equipment Services, MedAssets Supply Chain Systems. "We look forward to working with Siemens Medical Solutions Diagnostics to provide customers with a comprehensive range of solutions to meet the needs of laboratories today and tomorrow."

About MedAssets Inc.

MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, including 2,500 hospitals and 30,000 non-acute care healthcare providers. For more information, go to

About Siemens Medical Solutions Diagnostics

Siemens Medical Solutions Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that assist in the diagnosis, monitoring and management of disease. Products and services bring together the right balance of science, technology, and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe. Visit

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics -- such as Diagnostic Products Corporation and Bayer Diagnostics -- mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting

SOURCE Siemens Medical Solutions Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Childrens engages MedAssets for supply chain management
2. A Versatile Power Supply for All Electrophoresis Applications
3. RedPrairie Corp. introduces new supply chain software
4. Probe into gas gouging may educate Americans about pressures on oil supply
5. RedPrarie to provide Polaris with supply chain tech
6. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
7. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
8. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
9. Performance Comparisons of Commercial RT-PCR Systems
10. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
11. In Vivo Signal Transduction Pathway Reporting Systems
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
Breaking Biology News(10 mins):